Fundraising Fox
Invitrall
Founded 2024 · 4 employees on LinkedIn · 1 known investors
Find your way into Invitrall
Sign up to see every warm intro you have to Invitrall
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Invitrall team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Invitrall develops long-lasting, disease-representative human skin organoids from reprogrammed human cells, combining cell reprogramming, organoids, and machine learning to create human preclinical models. Its platform supports efficacy and repeated-dose toxicity testing for pharmaceutical and dermocosmetics companies developing skin drugs and cosmetics, as an alternative to animal testing.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Invitrall do?
- Invitrall develops long-lasting, disease-representative human skin organoids from reprogrammed human cells, combining cell reprogramming, organoids, and machine learning to create human preclinical models. Its platform supports efficacy and repeated-dose toxicity testing for pharmaceutical and dermocosmetics companies developing skin drugs and cosmetics, as an alternative to animal testing.
- Who are Invitrall's investors?
- Invitrall's investors include GRIDX.